vs
Side-by-side financial comparison of Nuvation Bio Inc. (NUVB) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
Nuvation Bio Inc. is the larger business by last-quarter revenue ($41.9M vs $31.4M, roughly 1.3× Ponce Financial Group, Inc.). On growth, Nuvation Bio Inc. posted the faster year-over-year revenue change (633.1% vs 37.6%).
Nuvation Bio Inc. is a clinical-stage biopharmaceutical company focused on researching and developing targeted oncology therapies to address unmet medical needs in difficult-to-treat cancer types. Its core pipeline features novel drug candidates targeting key oncogenic pathways, with primary operations and market presence centered in North America.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
NUVB vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.9M | $31.4M |
| Net Profit | — | $10.1M |
| Gross Margin | — | — |
| Operating Margin | -81.3% | 43.6% |
| Net Margin | — | 36.3% |
| Revenue YoY | 633.1% | 37.6% |
| Net Profit YoY | — | 245.6% |
| EPS (diluted) | $-0.11 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.9M | $31.4M | ||
| Q3 25 | $13.1M | $26.7M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $24.6M | ||
| Q4 24 | $5.7M | $22.8M | ||
| Q3 24 | — | $20.2M | ||
| Q2 24 | — | $20.2M | ||
| Q1 24 | $0 | $20.5M |
| Q4 25 | — | $10.1M | ||
| Q3 25 | $-55.8M | $6.5M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $3.2M | ||
| Q1 24 | $-14.8M | $2.4M |
| Q4 25 | — | — | ||
| Q3 25 | 74.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 26.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -81.3% | 43.6% | ||
| Q3 25 | -430.1% | 32.8% | ||
| Q2 25 | — | 30.2% | ||
| Q1 25 | — | 32.5% | ||
| Q4 24 | -944.5% | 19.6% | ||
| Q3 24 | — | 15.2% | ||
| Q2 24 | — | 21.8% | ||
| Q1 24 | — | 18.3% |
| Q4 25 | — | 36.3% | ||
| Q3 25 | -425.2% | 24.3% | ||
| Q2 25 | — | 23.0% | ||
| Q1 25 | — | 24.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | — | 12.1% | ||
| Q2 24 | — | 15.8% | ||
| Q1 24 | — | 11.8% |
| Q4 25 | $-0.11 | $0.43 | ||
| Q3 25 | $-0.16 | $0.27 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | $0.00 | $0.11 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | $-0.07 | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $529.2M | $126.2M |
| Total DebtLower is stronger | $47.2M | $596.1M |
| Stockholders' EquityBook value | $305.7M | $541.5M |
| Total Assets | $594.8M | $3.2B |
| Debt / EquityLower = less leverage | 0.15× | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $529.2M | $126.2M | ||
| Q3 25 | $549.0M | $146.6M | ||
| Q2 25 | — | $126.6M | ||
| Q1 25 | — | $129.9M | ||
| Q4 24 | $502.7M | $139.8M | ||
| Q3 24 | — | $155.8M | ||
| Q2 24 | — | $103.2M | ||
| Q1 24 | $597.0M | $134.7M |
| Q4 25 | $47.2M | $596.1M | ||
| Q3 25 | $47.1M | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $305.7M | $541.5M | ||
| Q3 25 | $325.9M | $529.8M | ||
| Q2 25 | — | $521.1M | ||
| Q1 25 | — | $513.9M | ||
| Q4 24 | $463.8M | $505.5M | ||
| Q3 24 | — | $504.6M | ||
| Q2 24 | — | $497.7M | ||
| Q1 24 | $594.0M | $493.7M |
| Q4 25 | $594.8M | $3.2B | ||
| Q3 25 | $601.6M | $3.2B | ||
| Q2 25 | — | $3.2B | ||
| Q1 25 | — | $3.1B | ||
| Q4 24 | $540.6M | $3.0B | ||
| Q3 24 | — | $3.0B | ||
| Q2 24 | — | $2.8B | ||
| Q1 24 | $613.1M | $2.8B |
| Q4 25 | 0.15× | 1.10× | ||
| Q3 25 | 0.14× | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-29.7M | $55.6M |
| Free Cash FlowOCF − Capex | — | $54.6M |
| FCF MarginFCF / Revenue | — | 173.9% |
| Capex IntensityCapex / Revenue | — | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-29.7M | $55.6M | ||
| Q3 25 | $-52.9M | $1.4M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $13.1M | ||
| Q4 24 | $-46.3M | $7.2M | ||
| Q3 24 | — | $-14.6M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | $-15.7M | $1.5M |
| Q4 25 | — | $54.6M | ||
| Q3 25 | — | $786.0K | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | — | $-15.0M | ||
| Q2 24 | — | $-2.6M | ||
| Q1 24 | — | $-315.0K |
| Q4 25 | — | 173.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 22.4% | ||
| Q1 25 | — | 52.6% | ||
| Q4 24 | — | 19.7% | ||
| Q3 24 | — | -74.1% | ||
| Q2 24 | — | -13.0% | ||
| Q1 24 | — | -1.5% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | — | 2.3% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | 11.9% | ||
| Q3 24 | — | 2.0% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | — | 2.46× | ||
| Q3 24 | — | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
